Skip to main content
. 2018 Jan-Feb;63(1):22–29. doi: 10.4103/ijd.IJD_581_17

Figure 3.

Figure 3

Presentation of the drug bound to major histocompatibility complex Class II by keratinocytes to CD4 cells resulting in (a) the release of CXC chemokine ligand 8 and granulocyte–macrophage colony-stimulating factor by both CD4 cells and keratinocytes which lead to (b) the migration of neutrophils into the epidermis and the conversion of the subcorneal blister into a sterile pustule. TCR: T-cell receptor.